Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges.

Cancer immunology, immunotherapy : CII - 1 May 2013

Srivastava Pramod K, Duan Fei

Abstract excerpt

The idea that individual tumors are antigenically unique has been around since the very dawn of our recognition of adaptive immune response to tumors. That idea has inspired a small number of attempts at individualized immunotherapy of human cancers. Such previous attempts for solid tumors have b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to Epitopes
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Neoplasms

Share to Precision Medicine

Share to Sequence Analysis, DNA

Share to T-Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 23604106
DOI: 10.1007/s00262-013-1422-x
PMCID: PMC3634982

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23604106-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges.PMID 23604106Read ↗

Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.Semantic proximity Read ↗

The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trialsSemantic proximity Read ↗

Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesSemantic proximity Read ↗

Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.Semantic proximity Read ↗

Applications of Immunogenomics to Cancer.Semantic proximity Read ↗

Human Tumor Antigens Yesterday, Today, and TomorrowSemantic proximity Read ↗

Personalized vaccines for cancer immunotherapy.Semantic proximity Read ↗

Unique Human Tumor Antigens: Immunobiology and Use in Clinical TrialsSemantic proximity Read ↗

Identification of human tumor antigens and its implications for diagnosis and treatment of cancerSemantic proximity Read ↗

HLA ligandome tumor antigen discovery for personalized vaccine approachSemantic proximity Read ↗

Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?Semantic proximity Read ↗

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.